Cyclo Therapeutics Inc
NASDAQ:CYTH

Watchlist Manager
Cyclo Therapeutics Inc Logo
Cyclo Therapeutics Inc
NASDAQ:CYTH
Watchlist
Price: 99 USD 12.08% Market Closed
Market Cap: 2.1B USD

Wall Street
Price Targets

CYTH Price Targets Summary
Cyclo Therapeutics Inc

There are no price targets for CYTH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cyclo Therapeutics Inc Competitors:
Price Targets
7774
Japan Tissue Engineering Co Ltd
150% Upside
PHARM
Pharming Group NV
45% Upside
EDT
Spectral Medical Inc
149% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
ZEAL
Zealand Pharma A/S
55% Upside
ORY
Oryzon Genomics SA
130% Upside
688105
Nanjing Vazyme Biotech Co Ltd
46% Upside
HPHA
Heidelberg Pharma AG
134% Upside

Revenue
Forecast

Revenue Estimate
Cyclo Therapeutics Inc

For the last 8 years the compound annual growth rate for Cyclo Therapeutics Inc's revenue is 2%. The projected CAGR for the next 3 years is 140%.

2%
Past Growth
140%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cyclo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cyclo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTH's stock price target?
Not Available

CYTH doesn't have any price targets made by Wall Street professionals.

What is Cyclo Therapeutics Inc's Revenue forecast?
Projected CAGR
140%

For the last 8 years the compound annual growth rate for Cyclo Therapeutics Inc's revenue is 2%. The projected CAGR for the next 3 years is 140%.

Back to Top